Match Document Document Title
US20140349939 METHODS FOR TREATING PAIN ASSOCIATED WITH CHRONIC PANCREATITIS  
The invention relates generally to methods for treating pain associated with chronic pancreatitis in patients. The methods comprise administering a therapeutically effective amount of a...
US20140256633 Relaxin Proteins For Use In The Diagnosis, Prevention or Treatment of Multiple Sclerosis  
The present invention relates to the use of one or more Relaxin proteins in methods for diagnoses and treatment of multiple sclerosis. The invention also provides compositions for use in...
US20120189619 METHODS FOR TREATING A SPINAL DISORDER OR OSTEOARTHRITIS USING DOMINANT NEGATIVE TISSUE NECROSIS FACTOR  
Effective methods of treating a spinal disorder or osteoarthritis associated with a proinflammatory agent in a patient in need of such treatment, the method comprising administering an effective...
US20120276152 SYSTEMS AND METHODS OF USING ZINC-CHELATOR TO TREAT MYOCARDIAL INFARCTION  
Methods and systems for treating an infarct by delivery of zinc chelator to modulate tissue.
US20130303455 PREDICTION AND PREVENTION OF PREECLAMPSIA  
The present disclosure relates to methods for assessing increased risk of preeclampsia in a pregnant woman. The methods described herein employ measuring relaxin levels, and optionally measuring...
US20130012441 PREDICTION AND PREVENTION OF PREECLAMPSIA  
The present disclosure relates to methods for assessing increased risk of preeclampsia in a pregnant woman. The methods described herein employ measuring relaxin levels, and optionally measuring...
US20140255518 Treatment and Prevention of Gastrointestinal Syndrome  
Compositions comprising a guanylyl cyclase C agonist in an amount effective to protect intestinal tissue against radiation or chemotherapy and methods of using such compositions to prevent GI...
US20150133378 METHOD FOR PREDICTING RISK OF EXPOSURE TO INTERSTITIAL FIBROSIS AND TUBULAR ATROPHY WITH CLUSTERIN  
A method for identifying a kidney transplant recipient at an increased risk of developing interstitial fibrosis or tubular atrophy which comprises obtaining a post-transplant urine sample from the...
US20110305634 Methods and systems for adenovirus interaction with desmoglein 2 (DSG2)  
The present invention provides compositions and methods for treating disorders associated with epithelial tissues.
US20110166070 METHOD OF PREVENTING PREMATURE DELIVERY  
The disclosure pertains to methods of decreasing the risk of premature birth and miscarriage in human females. Particularly, the disclosure provides methods of reducing cervical dialation and...
US20130130986 CANCER TREATMENT WITH RECOMBINANT VECTOR  
This disclosure provides modified cytosine deaminases(CDs). The disclosure further relates to cells and vector expressing or comprising such modified CDs and methods of using such modified CDs in...
US20140066377 Modulating Aquaporins with Relaxin  
The present disclosure relates to methods of modulating aquaporin channels. Particularly, the disclosure provides methods of modulating aquaporin channels in a tissue of a mammal by administering...
US20130053318 MODULATING AQUAPORINS WITH RELAXIN  
The present disclosure relates to methods of modulating aquaporin channels. Particularly, the disclosure provides methods of modulating aquaporin channels in a tissue of a mammal by administering...
US20140057832 USE OF RELAXIN TO INCREASE ARTERIAL COMPLIANCE  
The present invention provides methods for increasing arterial compliance. The methods generally involve administering to an individual in need thereof an effective amount of relaxin. The present...
US20140065102 METHODS FOR THE TREATMENT OF HEPATITIS B AND HEPATITIS D INFECTIONS  
It is disclosed a method for the treatment of HBV infection or HBV/HDV co-infection, the method comprising administering to a subject in need of treatment a first pharmaceutically acceptable agent...
US20110318401 TREATMENT OF LEG ULCERS USING PLACENTA DERIVED COLLAGEN BIOFABRIC  
The present invention provides a method of treating a leg ulcer comprising contacting the leg ulcer with a collagen biofabric. The leg ulcer may be a venous, arterial, diabetic or decubitus...
US20110135596 FUSION PROTEIN COMPRISING UBIQUITIN OR UBIQUITIN-LIKE PROTEIN, MEMBRANE TRANSLOCATION SEQUENCE AND BIOLOGICALLY ACTIVE MOLECULE AND USE THEREOF  
A transmembrane fusion protein including ubiquitin or a ubiquitin-like protein, a membrane translocation sequence linked to the C-terminus of the ubiquitin or ubiquitin-like protein, and a...
US20140005112 METHOD OF TREATING CHRONIC HEART FAILURE BY ADMINISTERING RELAXIN  
The present disclosure relates to methods for treating human subjects afflicted with chronic heart failure. The methods described herein employ administration of relaxin.
US20110144019 METHOD OF TREATING CHRONIC HEART FAILURE  
The present disclosure relates to methods for treating human subjects afflicted with chronic heart failure. The methods described herein employ administration of relaxin.
US20050026842 Compositions of Alpha3beta4 Receptor antagonists and opioid agonist analgesics  
Methods for use of pharmaceutical compositions containing an opioid agonist analgesic and an α3β4 nicotinic receptor antagonist effective to separate the brain-derived wanting of the opioid from...
US20140274901 PROANP COMPOSITIONS AND METHODS FOR TREATING ACUTE HEART FAILURE  
Materials and Methods related to using proANP to treat cardiorenal disease, including acute heart failure.
US20120238499 METHODS OF MODULATING APOPTOSIS BY ADMINISTRATION OF RELAXIN AGONISTS OR ANTAGONISTS  
The present invention relates to the discovery that relaxin is associated with the development or maturation of body tissues. Knockouts of the gene encoding relaxin result in various abnormalities...
US20120046218 GLYCOSAMINOGLYCAN-ANTAGONISING MCP-I MUTANTS AND METHODS OF USING SAME  
Novel mutants of human monocyte chemoattractant protein 1 (MCP-1) with increased glycosaminoglycan (GAG) binding affinity and knocked-out or reduced GPCR activity compared to wild type MCP-1, and...
US20110281801 PREDICTION AND PREVENTION OF PREECLAMPSIA  
The present disclosure relates to methods for detecting an increased risk of preeclampsia, determining the presence of preeclampsia, reducing the likelihood that preeclampsia will develop and...
US20060120993 Treatment of lesions of the soft tissues  
The invented remedy allows cleaning up the area from necrotic tissues and facilitating reduced perifocal oedema and infiltration as well as lessening pain syndrome during suppurative inflammation...
US20120039888 Methods Of Inhibiting Inflammation-Associated Tissue Damage By Inhibiting Neutrophil Activity  
The present invention relates to compositions and methods for treating inflammation-associated tissue damage, and particularly transfusion-associated, disorders, by inhibiting or reducing...
US20110034377 Exendin and Exendin Agonists for Eating Disorders  
Methods for treating conditions or disorders which can be alleviated by reducing food intake are disclosed which comprise administration of an effective amount of an exendin or an exendin agonist,...
US20140066881 CARDIAC RESUSCITATION METHODS AND KITS  
The invention provides methods of improving circulation in a subject undergoing a cardiac resuscitation protocol, reducing the risk of stroke in a subject undergoing a cardiac resuscitation...
US20110136739 Use of S1P Receptor Agonists in Heart Diseases  
The invention relates to the use of sphingosine-1-phosphate receptor agonist in the treatment of heart diseases.
US20150031616 USE OF RELAXIN TO TREAT PLACENTAL SYNDROMES  
The subject application relates to methods for treating a placental syndrome, wherein relaxin is administered during the late secretory/luteal (LS) phase of the menstrual cycle in women who have a...
US20130078218 HEPATITIS C THERAPIES  
The invention provides methods for treating hepatitis C viral infections and related viral infections, as well as compounds and compositions that are useful for treating such infections.
US20120220527 METHODS AND MATERIALS FOR REDUCING PLATELET COUNTS AND/OR PLATELET ADHESION  
This document relates to methods and materials for treating diseases or disorders associated with elevated platelet counts (e.g., essential thrombocythemia, secondary thrombocytosis, congenital...
US20100330159 System for transporting active substances in a biological system  
A stabilizer-free system for transporting active substances in a biological system of one or more active substances and magnetic particles, which is characterized in that the particles are...
US20140031291 PP2A REGULATORY SUBUNIT MODIFICATION IN DISEASE  
Disclosed herein are methods for the diagnosis, detection, and treatment of cardiovascular disease and symptoms thereof in a subject. Disclosed herein are methods of diagnosing ischemic heart...
US20130210730 METHOD OF TREATING DYSPNEA ASSOCIATED WITH ACUTE HEART FAILURE  
The disclosure pertains to methods of reducing decompensation through acute intervention including in subjects afflicted with acute decompensated heart failure. Particularly, the disclosure...
US20130116181 Method of treating dyspnea associated with acute heart failure  
The disclosure pertains to methods of reducing decompensation through acute intervention including in subjects afflicted with acute decompensated heart failure. Particularly, the disclosure...
US20120040903 METHOD FOR TREATING DYSPNEA ASSOCIATED WITH ACUTE HEART FAILURE  
The disclosure pertains to methods of reducing decompensation through acute intervention including in subjects afflicted with acute decompensated heart failure. Particularly, the disclosure...
US20120040902 METHOD OF TREATING DYSPNEA ASSOCIATED WITH ACUTE HEART FAILURE  
The disclosure pertains to methods of reducing decompensation through acute intervention including in subjects afflicted with acute decompensated heart failure. Particularly, the disclosure...
US20150018276 METHOD OF TREATMENT OF CANCER USING GUANOSINE 3', 5' CYCLIC MONOPHOSPHATE (CYCLIC GMP)  
A method of treating cancer through use of guanosine 3′,5′-cyclic monophosphate (cyclic GMP). Cyclic GMP decreases the number of human breast cancer and prostate adenocarcinoma as well as...
US20140045755 METHODS FOR TREATING SLEEP DISORDERS BY CHOLECYSTOKININ (CCK) RECEPTOR B ANTAGONISTS  
The present invention relates to a method for preventing or ameliorating a sleep-related breathing disorder. The method involves the use of one or a combination of cholecystokinin (CCK) receptor...
US20060008829 Multimarker panel based on PIGF for diabetes type 1 and 2  
The present invention relates to a method and means for diagnosing or risk stratification of co-morbidities, particularly cardiovascular complications in diabetes patients. The invention...
US20060122106 Prevention and/or treatment of inflammatory bowel disease using pyy or agonists thereof  
A novel use of PYY or a PYY agonist is disclosed for treating a bowel condition such as inflammatory bowel disease (e.g. ulcerative colitis and Crohn's disease), bowel atrophy, loss of bowel...
US20140357561 NATRIURETIC POLYPEPTIDE DELIVERY SYSTEMS  
This document provides natriuretic polypeptide delivery systems. For example, methods and materials related to natriuretic polypeptide delivery systems, methods and materials related to the use of...
US20140179605 NATRIURETIC POLYPEPTIDE DELIVERY SYSTEMS  
This document provides natriuretic polypeptide delivery systems. For example, methods and materials related to natriuretic polypeptide delivery systems, methods and materials related to the use of...
US20150203568 ALBUMIN FUSION PROTEINS  
The present invention encompasses albumin fusion proteins. Nucleic acid molecules encoding the albumin fusion proteins of the invention are also encompassed by the invention, as are vectors...
US20090082283 Dipeptides for Prevention of Muscle Breakdown and Microbial Infection  
The subject invention provides dipeptides useful in promoting healthy muscle tissues as well as effective immune responses. The dipeptides of the subject invention are particularly advantageous...
US20070015698 Treatment of skin, and wound repair, with thymosin beta 4  
Compositions and methods for treatment of skin utilizing thymosin β4.
US20140037712 METHODS FOR PREVENTING OR TREATING EYE DISEASES USING ADIPONECTIN  
A composition for preventing or treating an eye disease includes adiponectin as an active ingredient. Adiponectin as an active ingredient is eventually revealed to show prevention or therapeutic...
US20110003750 HUMAN 3 RELAXIN  
Human H3 preprorelaxin, human H3 prorelaxin, human H3 relaxin, human relaxin analogues having a modified A chain and/or a modified B chain are described. Also described are nucleic acid sequences...
US20070020294 Use of botulinum toxin for treatment of articular pathologies  
Use of botulinum toxin to obtain a product intended to be administered intramuscular with lissive effect in treating articular pathologies, particularly coxarthrosis, or arthrosis of the hip,...